Ignite Creation Date:
2025-12-24 @ 11:56 PM
Ignite Modification Date:
2026-01-22 @ 1:13 AM
Study NCT ID:
NCT02729051
Status:
COMPLETED
Last Update Posted:
2019-07-15
First Post:
2016-03-31
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06-29
Start Date Type:
ACTUAL
Primary Completion Date:
2017-05-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-05-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-31
First Submit QC Date:
None
Study First Post Date:
2016-04-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-25
Results First Submit QC Date:
None
Results First Post Date:
2019-07-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-05-03
Last Update Post Date:
2019-07-15
Last Update Post Date Type:
ACTUAL